Total planned funding: $402,452,119
Allocations
Countries/Regions
Eswatini | $402,452,119 |
Organizational Types
Private Contractor | $117,588,007 |
University | $72,532,772 |
Unknown | $60,864,659 |
NGO | $60,827,855 |
Own Agency | $49,015,399 |
Multi-lateral Agency | $14,782,982 |
FBO | $14,025,751 |
Host Country Government Agency | $10,757,533 |
Other USG Agency | $2,030,330 |
Implementing Agency | $26,831 |
Program Areas
Treatment | $124,743,094 |
Care | $119,516,737 |
Prevention | $69,217,946 |
Governance and Systems | $32,802,461 |
Testing | $29,032,938 |
Management and Operations | $27,138,943 |
Budget Codes
HTXS: Treatment: Adult Treatment | $93,792,449 |
HBHC: Care: Adult Care and Support | $49,767,520 |
HKID: Care: Orphans and Vulnerable Children | $43,258,311 |
HVCT: Testing: HIV Testing and Counseling | $29,032,938 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,581,052 |
HVMS: Management and Operations | $27,138,943 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $24,520,825 |
HTXD: Treatment: ARV Drugs | $22,189,368 |
HVTB: Care: TB/HIV | $17,537,688 |
OHSS: Health Systems Strengthening | $15,107,997 |
HVSI: Strategic Information | $12,488,099 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,402,326 |
PDCS: Care: Pediatric Care and Support | $8,953,218 |
PDTX: Treatment: Pediatric Treatment | $8,761,277 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,799,986 |
HLAB: Laboratory Infrastructure | $5,206,365 |
HMBL: Biomedical Prevention: Blood Safety | $913,757 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$60,162,195
Countries/Regions
Pact, Inc.:
$44,766,459
Countries/Regions
Not Available:
$42,554,793
Countries/Regions
Chemonics International:
$28,867,459
Countries/Regions